In the AD mouse model, supplementation of NAD+ precursors (such as nicotinamide) can improve mitochondrial function, reduce the deposition of Aβ and phosphorylation of Tau protein, thus improving the cognitive dysfunction of mice 53. Here, MAPT is linked to Alzheimer disease.